First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments
Year: 2013
Type: review
Source: Drugs
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W1989095457
